Investors may be over optimistic about the prospects for a new revenue source.

Investors are fixated on delayed product rollouts but long-term growth prospects are strong.

Board members step down over differences on the role of former CEO Richard White.

Market likes the payoff from early efforts at reining in costs.

Investors are overly optimistic about the prospects for this company. 

The market is underestimating the clear path to profitability.

We lower our fair value and believe the company is in an uncompetitive position but shares screen as undervalued due to investor pessimism.

A near monopoly in Australia pushes this company into global markets but progress has been slow.

We believe the company is in a transition year and results will improve.

An updated offer for international acquisition target.